This list is an analysis based on recent market events. It's not an investment recommendation.
About
Communications
Specialty Telecommunications
Information
Telecommunications Resellers
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.
The current price of CTY is $19.32 USD — it has increased by +5.29% in the past 24 hours. Watch City Therapeutics stock price performance more closely on the chart.
What is City Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange City Therapeutics stocks are traded under the ticker CTY.
What is City Therapeutics market cap?▼
Today City Therapeutics has the market capitalization of 972.42M
Does City Therapeutics pay dividends?▼
Yes, CTY dividends are paid quarterly. The last dividend per share was 0.37 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does City Therapeutics have?▼
As of November 22, 2026, the company has 75 employees.
In which sector is City Therapeutics located?▼
City Therapeutics operates in the Health & Wellness sector.
When did City Therapeutics complete a stock split?▼
City Therapeutics has not had any recent stock splits.
Where is City Therapeutics headquartered?▼
City Therapeutics is headquartered in Cambridge, United States.